UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 98

Sortiert nach

Peginterferon-Alfa2a Plus Ribavirin for 48 Versus 72 Weeks in Patients With Detectable Hepatitis C Virus RNA at Week 4 of Treatment

Gastroenterology (New York, N.Y. 1943), 2006-08, Vol.131 (2), p.451-460

2006

Link zum Volltext

Verfügbarkeit prüfen

Life-Threatening Cryoglobulinemia: Clinical and Immunological Characterization of 29 Cases

Seminars in arthritis and rheumatism, 2006-12, Vol.36 (3), p.189-196

2006

Link zum Volltext

Verfügbarkeit prüfen

Aplastic anemia and severe pancytopenia during treatment with peg-interferon, ribavirin and telaprevir for chronic hepatitis C

World journal of gastroenterology : WJG, 2015-05, Vol.21 (17), p.5421-5426

2015

Link zum Volltext

Verfügbarkeit prüfen

Response‐guided peg‐interferon plus ribavirin treatment duration in chronic hepatitis C: Meta‐analyses of randomized, controlled trials and implications for the future

Hepatology (Baltimore, Md.), 2011-09, Vol.54 (3), p.789-800

2011

Link zum Volltext

Verfügbarkeit prüfen

Peginterferon Plus Ribavirin and Sustained Virological Response in HCV-Related Cirrhosis: Outcomes and Factors Predicting Response

The American journal of gastroenterology, 2010-10, Vol.105 (10), p.2164-2172

2010

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Outcomes of Patients With HCV-Associated Cryoglobulinemic Vasculitis After Virologic Cure

Gastroenterology (New York, N.Y. 1943), 2018-08, Vol.155 (2), p.311-315.e6

2018

Link zum Volltext

Verfügbarkeit prüfen

Nosocomial acquisition of the hepatitis C virus

Journal of hepatology, 2008-06, Vol.48 (6), p.1020-1021

2008

Link zum Volltext

Verfügbarkeit prüfen

Dynamics of hepatitis C virus NS5A quasispecies during interferon and ribavirin therapy in responder and non-responder patients with genotype 1b chronic hepatitis C

Journal of general virology, 2005-04, Vol.86 (4), p.1067-1075

2005

Link zum Volltext

Verfügbarkeit prüfen

Clinico-biological characteristics and outcome of hepatitis C virus-positive patients with diffuse large B-cell lymphoma treated with immunochemotherapy

Annals of hematology, 2017-03, Vol.96 (3), p.405-410

2017

Link zum Volltext

Verfügbarkeit prüfen

Relationship of the genomic complexity of hepatitis C virus with liver disease severity and response to interferon in patients with chronic HCV genotype 1b interferon

Hepatology (Baltimore, Md.), 1999-03, Vol.29 (3), p.897-903

1999

Link zum Volltext

Verfügbarkeit prüfen

Development and validation of two models for early prediction of response to therapy in genotype 1 chronic hepatitis C

Hepatology (Baltimore, Md.), 2006-01, Vol.43 (1), p.72-80

2006

Link zum Volltext

Verfügbarkeit prüfen

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patients

AIDS (London), 2004-09, Vol.18 (13), p.F27-F36

2004

Link zum Volltext

Verfügbarkeit prüfen

Epidemiology of hepatitis C virus infection

Nephrology, dialysis, transplantation, 2000-01, Vol.15 (suppl-8), p.12-14

2000

Link zum Volltext

Verfügbarkeit prüfen

Treatment of Chronic Hepatitis B in Children with Recombinant Alfa Interferon: Different Response According to Age at Infection

Journal of clinical gastroenterology, 1993-12, Vol.17 (4), p.296-299

1993

Link zum Volltext

Verfügbarkeit prüfen

Comparative study of a modified competitive RT-PCR and amplicor HCV monitor assays for quantitation of hepatitis C virus RNA in serum

Journal of medical virology, 1999-05, Vol.58 (1), p.35-43

1999

Link zum Volltext

Verfügbarkeit prüfen

Prednisolone withdrawal therapy enhances the effect of human lymphoblastoid interferon in chronic hepatitis B

Journal of hepatology, 1996-12, Vol.25 (6), p.803-813

1996

Link zum Volltext

Verfügbarkeit prüfen

How hepatitis C virus modifies the immunological profile of Sjögren syndrome: analysis of 783 patients

Arthritis research & therapy, 2015-09, Vol.17 (1), p.250-250, Article 250

2015

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum: Peginterferon Plus Ribavirin and Sustained Virological Response in HCV-Related Cirrhosis: Outcomes and Factors Predicting Response

The American journal of gastroenterology, 2010-10, Vol.105 (10), p.2308-2308

2010

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis C virus infection mimicking primary Sjögren syndrome. A clinical and immunologic description of 35 cases

Medicine (Baltimore), 2001-01, Vol.80 (1), p.1-8

2001

Link zum Volltext

Verfügbarkeit prüfen

Neutrophil and Monocyte Function in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy with Regimens Containing Protease Inhibitors with and without Interferon

PloS one, 2016-11, Vol.11 (11), p.e0166631-e0166631

2016

Link zum Volltext

Verfügbarkeit prüfen

Fármacos para el tratamiento de la hepatitis B crónica

Gastroenterología y hepatología, 2008-03, Vol.31 (3), p.120-128

Sánchez-Tapias, José M

2008

Link zum Volltext

Verfügbarkeit prüfen

Dilemmas of organ transplantation from anti-HCV-positive donors

The Lancet (British edition), 1995-02, Vol.345 (8948), p.469-470

1995

Link zum Volltext

Verfügbarkeit prüfen

Pre-treatment with prednisolone does not improve the efficacy of subsequent alpha interferon therapy in chronic hepatitis C

Journal of hepatology, 2000-07, Vol.33 (1), p.135-141

2000

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 98

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(93)
Mit Volltextzugriff
(87)

Publikationsform

Artikel
(96)
Buchkapitel
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(78)
Life Sciences & Biomedicine
(77)
Humans
(74)
Biological And Medical Sciences
(56)
Medical Sciences
(52)
Female
(50)
Male
(49)
Middle Aged
(43)
Infectious Diseases
(39)
Adult
(37)
Gastroenterology & Hepatology
(36)
Viral Hepatitis
(35)
Human Viral Diseases
(34)
Viral Diseases
(34)
Hepacivirus - Genetics
(28)
Hepatitis C Virus
(28)
Aged
(18)
Antiviral Agents - Therapeutic Use
(17)
Hepatitis C, Chronic - Drug Therapy
(16)
Interferon-Alpha - Therapeutic Use
(16)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Peginterferon-Alfa2a Plus Ribavirin for 48 Versus 72 Weeks in Patients With Detectable Hepatitis C Virus RNA at Week 4 of Treatment

Life-Threatening Cryoglobulinemia: Clinical and Immunological Characterization of 29 Cases

Aplastic anemia and severe pancytopenia during treatment with peg-interferon, ribavirin and telaprevir for chronic hepatitis C

Response‐guided peg‐interferon plus ribavirin treatment duration in chronic hepatitis C: Meta‐analyses of randomized, controlled trials and implications for the future

Peginterferon Plus Ribavirin and Sustained Virological Response in HCV-Related Cirrhosis: Outcomes and Factors Predicting Response

Randomized trial comparing pegylated interferon alpha-2b versus pegylated interferon alpha-2a, both plus ribavirin, to treat chronic hepatitis C in human immunodeficiency virus patients

Long-Term Outcomes of Patients With HCV-Associated Cryoglobulinemic Vasculitis After Virologic Cure

Nosocomial acquisition of the hepatitis C virus

Dynamics of hepatitis C virus NS5A quasispecies during interferon and ribavirin therapy in responder and non-responder patients with genotype 1b chronic hepatitis C

Clinico-biological characteristics and outcome of hepatitis C virus-positive patients with diffuse large B-cell lymphoma treated with immunochemotherapy

Randomized trial comparing pegylated interferon α‐2b versus pegylated interferon α‐2a, both plus ribavirin, to treat chronic hepatitis C in human immunodeficiency virus patients

Relationship of the genomic complexity of hepatitis C virus with liver disease severity and response to interferon in patients with chronic HCV genotype 1b interferon

Development and validation of two models for early prediction of response to therapy in genotype 1 chronic hepatitis C

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patients

Epidemiology of hepatitis C virus infection

Treatment of Chronic Hepatitis B in Children with Recombinant Alfa Interferon: Different Response According to Age at Infection

Comparative study of a modified competitive RT-PCR and amplicor HCV monitor assays for quantitation of hepatitis C virus RNA in serum

Prednisolone withdrawal therapy enhances the effect of human lymphoblastoid interferon in chronic hepatitis B

How hepatitis C virus modifies the immunological profile of Sjögren syndrome: analysis of 783 patients

Corrigendum: Peginterferon Plus Ribavirin and Sustained Virological Response in HCV-Related Cirrhosis: Outcomes and Factors Predicting Response

Hepatitis C virus infection mimicking primary Sjögren syndrome. A clinical and immunologic description of 35 cases

Neutrophil and Monocyte Function in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy with Regimens Containing Protease Inhibitors with and without Interferon

Fármacos para el tratamiento de la hepatitis B crónica

Dilemmas of organ transplantation from anti-HCV-positive donors

Pre-treatment with prednisolone does not improve the efficacy of subsequent alpha interferon therapy in chronic hepatitis C

Suchergebnisse filtern